The technique of inhaling nanoparticle sensors followed by a urine test may offer the potential for faster and early detection of lung cancer.

Scientists from the Massachusetts Institute of Technology (MIT) have introduced this cutting-edge medical technology, presenting a simplified approach to diagnosing lung cancer.

Additionally, this innovation holds particular promise for low-and middle-income countries where the accessibility of computed tomography (CT) scanners is limited.